Geneva, July 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127092) titled 'Effects of the co-administration of Esketamine and Dexmedetomidine on postoperative nausea and vomiting in patients with temporomandibular joint disorder' on June 24.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine

Condition: Temporomandibular disorders (TMD)

Intervention: Experimental group:Esmketamine combined with dexmedetomidine

Recruitment Status: Not Recruiting

Phase: 4

Date of First Enrollment: 2026-07-01

Target Sample Size: Experimental group:91;Sufentanil group:91;

Countries of Recrui...